EUR 2.72
(-1.2%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 12.9 Million EUR | 17.11% |
2022 | 11.01 Million EUR | 14.58% |
2021 | 9.61 Million EUR | -10.8% |
2020 | 10.77 Million EUR | -37.96% |
2019 | 17.37 Million EUR | -2.88% |
2018 | 17.88 Million EUR | -5.33% |
2017 | 18.89 Million EUR | 45.47% |
2016 | 12.98 Million EUR | 10.75% |
2015 | 11.72 Million EUR | -19.16% |
2014 | 14.5 Million EUR | -48.74% |
2013 | 28.3 Million EUR | -29.26% |
2012 | 40 Million EUR | -44.02% |
2011 | 71.47 Million EUR | 143.24% |
2010 | 29.38 Million EUR | 7.24% |
2009 | 27.39 Million EUR | 1.08% |
2008 | 27.1 Million EUR | -0.84% |
2007 | 27.33 Million EUR | 0.07% |
2006 | 27.32 Million EUR | -1.91% |
2005 | 27.85 Million EUR | 22.37% |
2004 | 22.75 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 14.2 Million EUR | 0.0% |
2024 Q1 | 14.2 Million EUR | 10.08% |
2023 Q3 | 12.92 Million EUR | 3.36% |
2023 FY | 12.9 Million EUR | 17.11% |
2023 Q2 | 12.5 Million EUR | 0.0% |
2023 Q4 | 12.9 Million EUR | -0.15% |
2023 Q1 | 12.5 Million EUR | 13.48% |
2022 Q4 | 11.01 Million EUR | 0.0% |
2022 FY | 11.01 Million EUR | 14.58% |
2022 Q3 | 11.01 Million EUR | -3.38% |
2022 Q2 | 11.4 Million EUR | 0.0% |
2022 Q1 | 11.4 Million EUR | 18.59% |
2021 Q3 | 9.61 Million EUR | -1.91% |
2021 Q2 | 9.8 Million EUR | 1.03% |
2021 Q1 | 9.7 Million EUR | -9.99% |
2021 FY | 9.61 Million EUR | -10.8% |
2021 Q4 | 9.61 Million EUR | 0.0% |
2020 Q1 | 11.8 Million EUR | -32.07% |
2020 Q2 | 11.8 Million EUR | 0.0% |
2020 Q3 | 10.77 Million EUR | -8.67% |
2020 Q4 | 10.77 Million EUR | 0.0% |
2020 FY | 10.77 Million EUR | -37.96% |
2019 Q2 | 18.1 Million EUR | 0.0% |
2019 FY | 17.37 Million EUR | -2.88% |
2019 Q1 | 18.1 Million EUR | 1.19% |
2019 Q4 | 17.37 Million EUR | 0.0% |
2019 Q3 | 17.37 Million EUR | -4.02% |
2018 Q2 | 18.9 Million EUR | 0.0% |
2018 Q3 | 17.88 Million EUR | -5.36% |
2018 FY | 17.88 Million EUR | -5.33% |
2018 Q1 | 18.9 Million EUR | 0.03% |
2018 Q4 | 17.88 Million EUR | 0.0% |
2017 Q3 | 18.89 Million EUR | -6.92% |
2017 FY | 18.89 Million EUR | 45.47% |
2017 Q2 | 20.3 Million EUR | 0.0% |
2017 Q4 | 18.89 Million EUR | 0.0% |
2017 Q1 | 20.3 Million EUR | 56.29% |
2016 Q4 | 12.98 Million EUR | 0.0% |
2016 Q1 | 12.8 Million EUR | 9.14% |
2016 Q2 | 12.8 Million EUR | 0.0% |
2016 Q3 | 12.98 Million EUR | 1.48% |
2016 FY | 12.98 Million EUR | 10.75% |
2015 Q2 | 13.9 Million EUR | 1.46% |
2015 Q1 | 13.7 Million EUR | -5.57% |
2015 FY | 11.72 Million EUR | -19.16% |
2015 Q4 | 11.72 Million EUR | -11.82% |
2015 Q3 | 13.3 Million EUR | -4.32% |
2014 Q3 | 16.2 Million EUR | -4.71% |
2014 FY | 14.5 Million EUR | -48.74% |
2014 Q4 | 14.5 Million EUR | -10.44% |
2014 Q2 | 17 Million EUR | -38.18% |
2014 Q1 | 27.5 Million EUR | -2.83% |
2013 Q1 | 39.1 Million EUR | -2.27% |
2013 Q3 | 29.3 Million EUR | -3.93% |
2013 Q4 | 28.3 Million EUR | -3.41% |
2013 Q2 | 30.5 Million EUR | -21.99% |
2013 FY | 28.3 Million EUR | -29.26% |
2012 Q4 | 40 Million EUR | -2.18% |
2012 Q2 | 42.2 Million EUR | -33.65% |
2012 FY | 40 Million EUR | -44.02% |
2012 Q3 | 40.9 Million EUR | -3.08% |
2012 Q1 | 63.6 Million EUR | -11.01% |
2011 Q1 | 30.2 Million EUR | 2.78% |
2011 Q3 | 33.7 Million EUR | 6.31% |
2011 Q2 | 31.7 Million EUR | 4.97% |
2011 Q4 | 71.47 Million EUR | 112.08% |
2011 FY | 71.47 Million EUR | 143.24% |
2010 Q1 | 29.1 Million EUR | 6.21% |
2010 Q2 | 29.7 Million EUR | 2.06% |
2010 FY | 29.38 Million EUR | 7.24% |
2010 Q3 | 29.1 Million EUR | -2.02% |
2010 Q4 | 29.38 Million EUR | 0.97% |
2009 Q4 | 27.39 Million EUR | 0.0% |
2009 FY | 27.39 Million EUR | 1.08% |
2008 FY | 27.1 Million EUR | -0.84% |
2007 FY | 27.33 Million EUR | 0.07% |
2006 FY | 27.32 Million EUR | -1.91% |
2005 FY | 27.85 Million EUR | 22.37% |
2004 FY | 22.75 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Herantis Pharma Oyj | 6.74 Million EUR | -91.235% |
Nanoform Finland Oyj | 78.13 Million EUR | 83.49% |